These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

189 related articles for article (PubMed ID: 16893413)

  • 1. Vascular access thrombosis prophylaxis.
    Choudhury D
    Semin Dial; 2006; 19(4):335-42. PubMed ID: 16893413
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Improving access patency: pre-end-stage renal disease strategies.
    Schwab SJ
    J Am Soc Nephrol; 1998 Dec; 9(12 Suppl):S124-9. PubMed ID: 11443759
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Noninvasive methods to identify early vascular access dysfunction.
    Soule JL; Henry ML
    Semin Vasc Surg; 2007 Sep; 20(3):164-6. PubMed ID: 17884617
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Enhanced training in vascular access creation predicts arteriovenous fistula placement and patency in hemodialysis patients: results from the Dialysis Outcomes and Practice Patterns Study.
    Saran R; Elder SJ; Goodkin DA; Akiba T; Ethier J; Rayner HC; Saito A; Young EW; Gillespie BW; Merion RM; Pisoni RL
    Ann Surg; 2008 May; 247(5):885-91. PubMed ID: 18438128
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Secondary arteriovenous fistulas: converting prosthetic AV grafts to autogenous dialysis access.
    Slayden GC; Spergel L; Jennings WC
    Semin Dial; 2008; 21(5):474-82. PubMed ID: 18627564
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Current management of vascular access.
    Allon M
    Clin J Am Soc Nephrol; 2007 Jul; 2(4):786-800. PubMed ID: 17699495
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Obesity as a predictor of vascular access outcomes: analysis of the USRDS DMMS Wave II study.
    Chan MR; Young HN; Becker YT; Yevzlin AS
    Semin Dial; 2008; 21(3):274-9. PubMed ID: 18397205
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Adding access blood flow surveillance to clinical monitoring reduces thrombosis rates and costs, and improves fistula patency in the short term: a controlled cohort study.
    Tessitore N; Bedogna V; Poli A; Mantovani W; Lipari G; Baggio E; Mansueto G; Lupo A
    Nephrol Dial Transplant; 2008 Nov; 23(11):3578-84. PubMed ID: 18511608
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Innovative surgical approaches to maximize arteriovenous fistula creation.
    Shenoy S
    Semin Vasc Surg; 2007 Sep; 20(3):141-7. PubMed ID: 17884614
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Vascular access outcomes and medication use: a USRDS study.
    Yevzlin AS; Conley EL; Sanchez RJ; Young HN; Becker BN
    Semin Dial; 2006; 19(6):535-9. PubMed ID: 17150056
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Angiotensin converting enzyme inhibitors maintain polytetrafluroethylene graft patency.
    Sajgure A; Choudhury A; Ahmed Z; Choudhury D
    Nephrol Dial Transplant; 2007 May; 22(5):1390-8. PubMed ID: 17267534
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Preserving function and long-term patency of dialysis access.
    Akoh JA; Hakim NS
    Ann R Coll Surg Engl; 1999 Sep; 81(5):339-42. PubMed ID: 10645178
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Review of microsurgery and arteriovenous fistulae for hemodialysis.
    Dorsett-Martin WA
    Microsurgery; 2006; 26(2):122-5. PubMed ID: 16538635
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The advantages of end-to-side arteriovenous anastomosis over the other two types of arteriovenous anastomosis in dialysis patients.
    Galić G; Kvesić A; Tomić M; Rebac Z; Brekalo Z; Martinović V; Vuckov S
    Coll Antropol; 2008 Mar; 32(1):109-14. PubMed ID: 18494195
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The native arteriovenous fistula in 2007. Research needs.
    Besarab A; Ravani P; Spergel LM; Roy-Chaudhury P; Asif A
    J Nephrol; 2007; 20(6):668-73. PubMed ID: 18046668
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Predictors of early dialysis vascular-access failure after thrombolysis.
    Crikis S; Lee D; Brooks M; Power DA; Ierino FL; Levidiotis V
    Am J Nephrol; 2008; 28(2):181-9. PubMed ID: 17960056
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Patency rate and complications of vascular access grafts for hemodialysis in lower extremities.
    Salimi J
    Saudi J Kidney Dis Transpl; 2008 Nov; 19(6):929-32. PubMed ID: 18974578
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Vascular access for dialysis in elderly: AVF versus permanent CVC].
    Brunori G; Bandera A; Valente F; Laudon A
    G Ital Nefrol; 2008; 25(6):614-8. PubMed ID: 19048553
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Recurrent vascular access trombosis associated with the prothrombin mutation G20210A in a adult patient in haemodialysis].
    Quintana LF; Coll E; Monteagudo I; Collado S; López-Pedret J; Cases A
    Nefrologia; 2005; 25(4):442-4. PubMed ID: 16231514
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Vascular access for haemodialysis.
    Murphy GJ; White SA; Nicholson ML
    Br J Surg; 2000 Oct; 87(10):1300-15. PubMed ID: 11044154
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.